Company news
Avenir Wellness Solutions Inc. news in 2019
Avenir Wellness Solutions Inc.'s news releases, calls and decks from 2019, newest first.
CURE Pharmaceutical [OTCQB: CURR] to Present at the 12th Annual LD Micro Main Event Investor Conference
December 5, 2019
CURE Pharmaceutical [OTC: CURR] Names Canopy Rivers’ Chairman, John K. Bell, To Board of Directors
November 19, 2019
CURE Pharmaceutical [OTCQB: CURR] Takes First Step to Acquire Coeptis Pharmaceuticals and its Combination Drug for Osteoarthritis Pain and Hypertension
November 14, 2019
CURE Pharmaceutical [OTCQB: CURR] Debuts CUREform Drug Delivery Line Adding Chewables and Emulsions
October 9, 2019
CURE Pharmaceutical Promotes Dr. Vered Gigi to Chief Scientific Officer
October 1, 2019
CURE Pharmaceutical [OTCQB: CURR] Takes First Step To Secure Hemp CBD Supply Chain by Partnering with Fytiko Farms
August 21, 2019
CURE Pharmaceutical Expands Board with Two Women Directors
August 7, 2019
CURE Pharmaceutical [OTCQB: CURR] Secures Patent on High Loading of Active Ingredient in Oral Thin Films
July 24, 2019
CURE Pharmaceutical [OTCQB: CURR] Secures Patent on Oral Thin Films With Bi-Phasic Release of Natural Ingredients
July 16, 2019
CURE Pharmaceutical [OTCQB: CURR] and Canopy Growth to Produce CBD Oral Thin Films
June 19, 2019
CURE Pharmaceutical to Present at the 9th Annual LD Micro Invitational
May 30, 2019
CURE Pharmaceutical Secures Patent on Oral Thin Film Containing Bioactive Cannabinoid Molecules
May 22, 2019
CURE Pharmaceutical Expands Leadership Team with Key New Hires
May 20, 2019
CURE Pharmaceutical (OTCQB: CURR) Closes Acquisition Of Privately-Held Chemistry Holdings Inc.
May 14, 2019
Meroven LLC and CURE Pharmaceutical Enter Exclusive Marketing and Distribution Agreement for Spee-D for the USA
May 2, 2019
CURE Pharmaceutical Extends Closing Of Privately-Held Chemistry Holdings Inc. Acquisition to May 13
May 1, 2019
Cure Pharmaceutical [OTCQB: CURR] to Present at the “Planet MicroCap Showcase 2019”
April 30, 2019
CURE Pharmaceutical Named “Innovative Business of the Year” By Oxnard Chamber of Commerce
April 26, 2019
United Smart Cities and Cure Pharmaceutical Launch Global Healthcare Awareness Initiative
April 9, 2019
CURE Pharmaceutical to Acquire Privately-Held Chemistry Holdings Inc., Expanding Its Technology Platform in Oral Drug Delivery
April 1, 2019
CURE Pharmaceutical Announces Completion of FDA Pre-IND Review and Clinical Trial Plans for CUREfilm Blue™ for Erectile Dysfunction
March 26, 2019
CURE Pharmaceutical Expands U.S. DEA Approval to Manufacture Pharmaceuticals Using Whole Cannabis Plant
March 12, 2019
National Healthcare Economics and Policy Expert Ruben Jose King-Shaw Jr Joins CURE Pharmaceutical’s Board of Directors
January 29, 2019
CURE Pharmaceutical Appoints Chairman, Adds Member to its Board of Directors
January 15, 2019
CURE Pharmaceutical To Present at Benzinga Cannabis Capital Conference
January 9, 2019